On the other hand, Danowski et al. reported that in 418 SLE patients with APS, aβ2GPI IgA were not associated with any symptoms of APS, in contrast to aβ2GPI IgG/IgM [50]. This evidence concerns the gene CD40LG and autoimmune polyendocrinopathy.